Klemen Bedenčič1, Martina Kavčič2, Nataša Faganeli3, Rene Mihalič3, Blaž Mavčič4, Jožica Dolenc5, Zlatka Bajc5, Rihard Trebše6. 1. Department of Orthopaedics, General Hospital Novo Mesto, Novo Mesto, Slovenia. 2. Medical Microbiology Department, Institute of Public Health, Koper, Slovenia. 3. Valdoltra Orthopaedic Hospital, Jadranska Cesta 31, 6280, Ankaran, Slovenia. 4. Orthopaedic Clinic University Clinical Centre, Ljubljana, Slovenia. 5. National Veterinary Institute, Ljubljana, Slovenia. 6. Valdoltra Orthopaedic Hospital, Jadranska Cesta 31, 6280, Ankaran, Slovenia. rihard.trebse@ob-valdoltra.si.
Abstract
BACKGROUND: Undiagnosed low-grade prosthetic joint infections (PJI) are recognized as an important reason for early failure of presumably aseptic revisions. Preoperatively administered antimicrobial prophylaxis reduces the incidence of PJI but it may reduce the sensitivity of microbiologic periprosthetic tissue cultures and consequently increase the incidence of undiagnosed septic prosthetic joint failures, which can lead to catastrophic serial revisions. QUESTIONS/PURPOSES: We wished to determine whether administration of preoperative antibiotics decreases the likelihood of diagnosing PJI in patients undergoing revision hip or knee arthroplasty in whom infection is suspected. METHODS: We prospectively enrolled and evaluated 40 patients (29 with THAs and 11 with TKAs) who met the following inclusion criteria: older than 18 years, with suspected PJI of unknown cause, undergoing surgical revision. After arthrotomy, three tissue samples were obtained for microbiologic analysis and diagnosis, and antimicrobial prophylaxis (cefazolin 2 g intravenously) then was administered. Later during the procedure, but before débridement and irrigation, the second set of three tissue samples was obtained from the same surgical area and was cultured. Tissue concentration of prophylactic antibiotic was verified with the second set of samples. A positive culture result was defined as one or more positive cultures (growth on agar at or before 14 days). We then compared the yield on the microbiologic cultures obtained before administration of antibiotics with the yield on the cultures obtained after antibiotics were administered. An a priori analysis was performed; with the numbers available, we had 98% power to detect a difference in diagnostic sensitivity of 33%. RESULTS: With the numbers available, we found no difference in the likelihood that an infection would be diagnosed between the samples obtained before and after administration of antimicrobial prophylaxis (odds ratio [OR] for positive microbial culture = 0.99; 95% CI, 0.40-2.48; p = 0.99). All measured tissue concentrations of cefazolin were greater than the minimum inhibitory concentration, therefore we found that antibiotic prophylaxis was adequate at the time of second-set tissue specimen recovery. CONCLUSIONS: Results from this small, prospective series suggest that preoperative antimicrobial prophylaxis may be administered safely even in patients undergoing revision hip or knee arthroplasty in which microbiologic sampling is planned without compromising the diagnostic sensitivity of tissue sample cultures. However, before applying our results more generally, our findings need to be confirmed in larger, multicenter studies that would allow evaluation by sex, procedure, bacteriology, and other potentially important factors. LEVEL OF EVIDENCE: Level I, diagnostic study.
BACKGROUND: Undiagnosed low-grade prosthetic joint infections (PJI) are recognized as an important reason for early failure of presumably aseptic revisions. Preoperatively administered antimicrobial prophylaxis reduces the incidence of PJI but it may reduce the sensitivity of microbiologic periprosthetic tissue cultures and consequently increase the incidence of undiagnosed septic prosthetic joint failures, which can lead to catastrophic serial revisions. QUESTIONS/PURPOSES: We wished to determine whether administration of preoperative antibiotics decreases the likelihood of diagnosing PJI in patients undergoing revision hip or knee arthroplasty in whom infection is suspected. METHODS: We prospectively enrolled and evaluated 40 patients (29 with THAs and 11 with TKAs) who met the following inclusion criteria: older than 18 years, with suspected PJI of unknown cause, undergoing surgical revision. After arthrotomy, three tissue samples were obtained for microbiologic analysis and diagnosis, and antimicrobial prophylaxis (cefazolin 2 g intravenously) then was administered. Later during the procedure, but before débridement and irrigation, the second set of three tissue samples was obtained from the same surgical area and was cultured. Tissue concentration of prophylactic antibiotic was verified with the second set of samples. A positive culture result was defined as one or more positive cultures (growth on agar at or before 14 days). We then compared the yield on the microbiologic cultures obtained before administration of antibiotics with the yield on the cultures obtained after antibiotics were administered. An a priori analysis was performed; with the numbers available, we had 98% power to detect a difference in diagnostic sensitivity of 33%. RESULTS: With the numbers available, we found no difference in the likelihood that an infection would be diagnosed between the samples obtained before and after administration of antimicrobial prophylaxis (odds ratio [OR] for positive microbial culture = 0.99; 95% CI, 0.40-2.48; p = 0.99). All measured tissue concentrations of cefazolin were greater than the minimum inhibitory concentration, therefore we found that antibiotic prophylaxis was adequate at the time of second-set tissue specimen recovery. CONCLUSIONS: Results from this small, prospective series suggest that preoperative antimicrobial prophylaxis may be administered safely even in patients undergoing revision hip or knee arthroplasty in which microbiologic sampling is planned without compromising the diagnostic sensitivity of tissue sample cultures. However, before applying our results more generally, our findings need to be confirmed in larger, multicenter studies that would allow evaluation by sex, procedure, bacteriology, and other potentially important factors. LEVEL OF EVIDENCE: Level I, diagnostic study.
Authors: Andrej Trampuz; Arlen D Hanssen; Douglas R Osmon; Jayawant Mandrekar; James M Steckelberg; Robin Patel Journal: Am J Med Date: 2004-10-15 Impact factor: 4.965
Authors: Matthew W Tetreault; Nathan G Wetters; Vinay Aggarwal; Michael Mont; Javad Parvizi; Craig J Della Valle Journal: Clin Orthop Relat Res Date: 2014-01 Impact factor: 4.176
Authors: Lauren K Dutton; Katharine M Hinchcliff; Anthony L Logli; Katherine E Mallett; Gina A Suh; Marco Rizzo Journal: JB JS Open Access Date: 2022-03-24
Authors: O Robineau; E Talagrand-Reboulh; B Brunschweiler; F Jehl; E Beltrand; F Rousseau; N Blondiaux; A Grillon; C Joseph; P Lambotte; P Boyer; Eric Senneville Journal: Eur J Clin Microbiol Infect Dis Date: 2021-05-20 Impact factor: 3.267
Authors: Timothy L Tan; Michael M Kheir; Noam Shohat; Dean D Tan; Matthew Kheir; Chilung Chen; Javad Parvizi Journal: JB JS Open Access Date: 2018-07-12
Authors: Geertje A M Govaert; Richard Kuehl; Bridget L Atkins; Andrej Trampuz; Mario Morgenstern; William T Obremskey; Michael H J Verhofstad; Martin A McNally; Willem-Jan Metsemakers Journal: J Orthop Trauma Date: 2020-01 Impact factor: 2.884
Authors: Daniel Pérez-Prieto; Pedro Hinarejos; Albert Alier; Lluïsa Sorlí; Santos Martínez; Lluís Puig; Juan C Monllau Journal: BMC Musculoskelet Disord Date: 2021-08-02 Impact factor: 2.362